S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Laser breakthrough could send stock soaring 2,467% (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
Laser breakthrough could send stock soaring 2,467% (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Laser breakthrough could send stock soaring 2,467% (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
OTCMKTS:ADDXF

Addex Therapeutics (ADDXF) Stock Forecast, Price & News

$0.99
0.00 (0.00%)
(As of 02/3/2023)
Compare
Today's Range
$0.99
$0.99
50-Day Range
$0.99
$0.99
52-Week Range
$0.99
$0.99
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADDXF stock logo

About Addex Therapeutics (OTCMKTS:ADDXF) Stock

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot-Marie-Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

ADDXF Price History

ADDXF Stock News Headlines

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Addex Completes $5.0 Million Equity Financing
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Addex Therapeutics FY22 Loss Widens, Income Down
Trevi Therapeutics IPO: At Phase 3 Of Development
See More Headlines
Receive ADDXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ADDXF Company Calendar

Today
10/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ADDXF
CIK
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.25
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Timothy Mark Dyer (Age 54)
    Co-Founder, CEO & Director
  • Dr. Roger G. Mills M.D. (Age 65)
    Chief Medical Officer & Director
  • Mr. Lénaic Teyssédou (Age 36)
    Head of Fin.
  • Dr. Jean-Philippe Rocher Ph.D. (Age 63)
    Head of Discovery - Chemistry
  • Dr. Robert Lutjens (Age 54)
    Head of Discovery - Biology
  • Dr. Mikhail Kalinichev Ph.D. (Age 54)
    Head of Translational Science
  • Dr. Werner Henrichi Ph.D. (Age 79)
    Consultant













ADDXF Stock - Frequently Asked Questions

How have ADDXF shares performed in 2023?

Addex Therapeutics' stock was trading at $0.99 at the beginning of 2023. Since then, ADDXF stock has increased by 0.0% and is now trading at $0.99.
View the best growth stocks for 2023 here
.

What is Addex Therapeutics' stock symbol?

Addex Therapeutics trades on the OTCMKTS under the ticker symbol "ADDXF."

How do I buy shares of Addex Therapeutics?

Shares of ADDXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addex Therapeutics' stock price today?

One share of ADDXF stock can currently be purchased for approximately $0.99.

How can I contact Addex Therapeutics?

The official website for the company is www.addextherapeutics.com. The company can be reached via phone at 41 22 884 1555.

This page (OTCMKTS:ADDXF) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -